home / stock / tcon / tcon news

TCON News and Press, TRACON Pharmaceuticals Inc. From 05/06/20

Stock Information
Company Name: TRACON Pharmaceuticals Inc.
Stock Symbol: TCON
Market: OTC
Website: traconpharma.com
Menu
TCON TCON Quote TCON Short TCON News TCON Articles TCON Message Board
Get TCON Alerts

News, Short Squeeze, Breakout and More Instantly...
TCON - TRACON to Report First Quarter 2020 Financial Results and Company Highlights on May 13, 2020

SAN DIEGO, May 06, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. compan...
TCON - Axsome's Alzheimer's Positive Results, And Other News: The Good, Bad And Ugly Of Biopharma

Axsome Therapeutics Reports Positive Alzheimer Results Axsome Therapeutics Inc. ( AXSM ) reported that its lead drug candidate AXS 05 met its primary endpoint in the ADVANCE-1 Phase 2/3 trial. The ADVANCE-1 study was a randomized, double-blind, controlled, trial and had 366 patients suffe...

TCON - Tracon Pharma up 17% premarket on rights to cancer candidate TRC253

TRACON Pharmaceuticals (NASDAQ: TCON ) announces  that it has retained global rights to TRC253 after Johnson & Johnson (NYSE: JNJ ) unit Janssen Pharmaceutica N.V. decided not to exercise its option for worldwide rights following a review of Phase 2 data in certain prostate cancer ...

TCON - TRACON Pharmaceuticals Retains Global Rights to TRC253 Following Completion of a Phase 1/2 Trial

SAN DIEGO, April 24, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, today announced that it has retained global rights to and has sole respo...
TCON - TRACON Pharmaceuticals Announces Appointment of Biotechnology Industry Veteran Shahe Garabedian as Senior Vice President of Quality Assurance and Granting of Inducement Award

SAN DIEGO, April 14, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. comp...

TCON - TRACON Announces May 8 Date for Type B Teleconference Meeting with FDA to Discuss Trial Design for ENVASARC: A Potential Pivotal Study of Envafolimab in Sarcoma

SAN DIEGO, April 06, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. comp...

TCON - TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of Directors

SAN DIEGO, March 19, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. comp...
TCON - TRACON Announces Submission of Request for Type B Meeting with FDA to Discuss Trial Design for ENVASARC: A Potential Pivotal Study of Envafolimab in Sarcoma

SAN DIEGO, March 16, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. comp...

TCON - Stitch Fix, Tracon and Inovio Pharmaceuticals among premarket losers

Stitch Fix (NASDAQ: SFIX ) -29% on Q4 revenue growth . More news on: Stitch Fix, Inc., TRACON Pharmaceuticals, Inc., Spherix Incorporated, Stocks on the move, , Read more ...

TCON - Santen and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular Degeneration

OSAKA, Japan and SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- Santen Pharmaceutical Co., Ltd. (Head Office: Osaka; hereinafter, “Santen”) and TRACON Pharmaceuticals, Inc. (Head Office: San Diego, CA; hereinafter, “TRACON”) today announced the discontinuation of ...
Previous 10 Next 10